Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Quality of Life and Post-Surgical Complications in Patients on Chronic Antiplatelet Therapy with Proximal Femur Fracture, 12-Month Follow-Up after Implementing a Strategy to Shorten the Time to Surgery

  • Merchán Galvis, Ángela María|||0000-0003-2375-5513
  • Anaya, Rafael|||0000-0003-2746-5388
  • Rodriguez Prieto, Mireia|||0000-0002-4462-534X
  • Llorca Garcia, Jordi
  • Castejón, Mercé
  • Gil Sanchez, José María|||0000-0003-1422-0883
  • Millan, Angélica
  • Estepa Calvo, Verónica
  • Cardona, Elena
  • García Sánchez, Yaiza|||0000-0003-0894-1721
  • Ruiz Pardos, Ana
  • Martinez-Zapata, Mª José|||0000-0002-5836-1138
We evaluated a strategy to shorten the time from admission to surgery in patients with proximal femur fractures on chronic antiplatelet therapy. We reported a 12-month follow-up on complications and quality of life (QoL). Multicentre, open-label, randomized, parallel clinical trial. Patients were randomized to either early platelet function-guided surgery (experimental group) or delayed surgery (control group). Medical and surgical complications and QoL (EQ-5D-5L questionnaire) were assessed during the hospital stay, and after hospital discharge at 30 days, and 6 and 12 months. From 156 randomized patients, 143 patients underwent surgery. The mean age was 85.5 (7.8) years and 68.0% were female. After hospital discharge, 5.7% of patients had surgical wound complications and 55.9% had medical complications, with 42.7% having serious adverse events. QoL improved significantly after surgery, with the best scores at the six-month follow-up. The overall mortality was 32.2%. There were no differences between early and delayed surgery groups in any assessed outcomes. It seems safe to reduce the time of surgery under neuraxial anaesthesia in patients with hip fractures on chronic antiplatelet therapy by platelet function testing. QoL in particular improves in the first six months after surgery.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Economic evaluation of a strategy to shorten the time to surgery with neuraxial anaesthesia compared with usual clinical practice in patients on chronic antiplatelet therapy with a proximal femur fracture

  • Delgado Espinoza, Claudia Erika|||0009-0009-9089-4784
  • Antonijoan Arbós, Rosa Ma|||0000-0002-7099-5125
  • Gich, Ignasi|||0000-0003-3975-6588
  • Anaya, Rafael|||0000-0003-2746-5388
  • Rodriguez, M.
  • Millan, A.
  • Llorca Garcia, Jordi
  • Usua, Gemma|||0000-0002-9333-6544
  • Ruiz Pardos, Ana
  • Merchán-Galvis, A.
  • Martinez-Zapata, Mª José|||0000-0002-5836-1138
Introduction: Before implementing a new health care strategy, it is important to assess effectiveness but also to perform an economic evaluation. The goal of the present study was to perform a comparative economic evaluation of a new strategy aimed at using proposed implementation of the Plateletworks guidance (measurement of platelet function) with usual practice (delayed time to surgery) in patients on chronic antiplatelet treatment and scheduled for surgery with neuraxial anaesthesia due to proximal femur fracture. Methods: This is an economic evaluation carried out alongside a randomised controlled clinical trial at four centres in Spain. Patients were randomised to undergo either early platelet function-guided surgery (experimental group) or delayed surgery (control group). As AFFEcT trial results demonstrated significative difference between groups in the primary efficacy endpoint, the median time to surgery, a cost-effectiveness analysis was performed. Direct costs associated with hospitalisation until one-month post-discharge were considered and measured from a hospital perspective. All costs were reported in euros. Analyses were performed on a per protocol basis. Effectiveness outcome measures were the incremental cost and incremental cost per reduction in days to surgery. A deterministic sensitivity analysis was implemented to quantify uncertainty. Results: A total of 156 patients were randomized to the two groups (n = 78 per group). A total of 143 patients were included in the per protocol population (75 and 68 patients in the experimental and control groups, respectively). The median time to surgery was 2.30 days (IQR: 1.53-3.73) in the experimental group and 4.87 days (4.36-5.60) in the control group (a reduction of 2.40 days). Total costs during the 1-month study perioperative period were higher in the delayed surgery group (€18,495.19) than for the early surgery group (€16,497.59). The incremental cost was negative (€1,997.60), a statistically significant difference (P < 0.05). As measured by the reduction in time (days) to surgery, the incremental cost-effectiveness ratio (ICER) for early surgery was negative (777.28€/day). Sensitivity analysis demonstrated consistent cost saving. Conclusion: For patients on chronic antiplatelet treatment scheduled to undergo surgery for proximal femur fracture, an individualised strategy guided by a platelet function testing is a cost-saving and cost-effective strategy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Early surgery with neuraxial anaesthesia in patients on chronic antiplatelet therapy with a proximal femur fracture, Multicentric randomised clinical trial

  • Anaya, Rafael|||0000-0003-2746-5388
  • Rodriguez Prieto, Mireia|||0000-0002-4462-534X
  • Millan, Angélica
  • Reguant, Francesca
  • Llorca Garcia, Jordi
  • Guilabert, Patricia|||0000-0001-6894-2342
  • Ruiz Pardos, Ana
  • Pantoja, Efrain|||0000-0003-4095-8988
  • Gil Sanchez, José María|||0000-0003-1422-0883
  • Moral, Victoria|||0000-0002-4061-0378
  • Merchán Galvis, Ángela María|||0000-0003-2375-5513
  • Martinez-Zapata, Mª José|||0000-0002-5836-1138
Background: Patients with proximal femur fracture on antiplatelet treatment benefit from early surgery. Our goal was to perform early surgery under neuraxial anaesthesia when indicated by the platelet function test. Methods: We conducted a multicentre randomised open-label parallel clinical trial. Patients were randomised to either early platelet function-guided surgery (experimental group) or delayed surgery (control group). Early surgery was programmed when the functional platelet count (as measured by Plateletworks) was.